Beginner
- Dose
- 0,6 mg por semana Original in PT-BR
- Frequency
- Uma vez por semana Original in PT-BR
- Duration
- Dose mais baixa estudada Original in PT-BR
- Notes
- O site apresenta como dose de ensaio, não recomendação. Original in PT-BR
KNOWLEDGE · COMPOUNDS
Survodutide
Also known as: BI 456906
MetabolicClinical trials
Overview
Written by EagleThis description was written by Eagle in each of the three languages. It is not imported text and carries no translation warning. What it says comes from the compound’s own composition, its pharmacological class and what the library records — no efficacy claim, and no Eagle recommendation of use.
É um composto investigacional; o site informa que não é aprovado pela FDA até junho de 2026.
Survodutide is catalogued under Metabolic. 1 Eagle article in this library references this compound.
- Category
- Metabolic
- Research stage
- Clinical trials — Ensaios clínicos Original in PT-BR
- Eagle articles on this compound
- 1 Eagle article
Mechanism
O site descreve survodutida como agonista duplo dos receptores GLP-1 e glucagon, estudado para perda de peso e MASH. Original in PT-BR
Eagle articles on this compound
Chemical information
- CAS
- Not recorded in the source.
- Molecular formula
- Not recorded in the source.
- Molecular weight
- Not recorded in the source.
- Sequence
- Not recorded in the source.
- Amino acids
- Not recorded in the source.
- Solubility
- Not recorded in the source.
- Stability
- Not recorded in the source.
- Half-life
- Not recorded in the source.
- Bioavailability
- Not recorded in the source.
- Onset
- Not recorded in the source.
- Routes
- Subcutânea
Research references
No individual dosing recommendation is given. Values are as recorded in the source, with species and route stated where known.
No research references recorded in the source.
Safety
No safety information recorded in the source.
Reported protocols
Recorded in the imported source as community protocols. They are NOT Eagle protocols, were not reviewed by Eagle, and are not a dosing recommendation, a prescription or clinical guidance. Values appear exactly as recorded, in the language they were written in.
Intermediate
- Dose
- 2,4–3,6 mg por semana Original in PT-BR
- Frequency
- Uma vez por semana Original in PT-BR
- Duration
- Doses intermediárias estudadas Original in PT-BR
- Notes
- A tabela do site registra 2,4 mg e 3,6 mg separadamente. Original in PT-BR
Advanced
- Dose
- 4,8 mg por semana Original in PT-BR
- Frequency
- Uma vez por semana Original in PT-BR
- Duration
- Após escalonamento de 20 semanas no estudo de obesidade Original in PT-BR
- Notes
- Dose máxima da tabela; não é recomendação de dose. Original in PT-BR
Vial sizes: 6 mg · 10 mg — Peptide Calculator
Interactions
No relations recorded in the source.
Related
No linked article matches that search.